ada guidelines glp 1 for Diabetes 2026 #ada #diabetes @dr_samia_asim Pharmacologic Approaches to Glycemic Treatment

A microdose of GLP-1 (glucagon-like peptide-1) is an informal, non-standard term referring to the administration of GLP-1 receptor agonist medications at doses substantially lower than those licensed and recommended by UK regulatory authorities such as the MHRA (Medicines and Healthcare products Regulatory Agency) and NICE (National Institute for Health and Care Excellence)

It will undoubtedly be most effective in diabetic / prediabetic populations, with some great use cases for carbohydrate lovers

If you are interested in emerging obesity treatments such as cagrilintide, retatrutide, or potential combination approaches, the most appropriate first step is to speak with your GP or a specialist in obesity medicine

Avoid excessive heat, contamination, and improper handling during storage and evaluation.

Print it